Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Wound Infusion of Bupivacaine in Axillary Clearance
NCT01314144Phase 3Unknown
- Sponsor
- Cork University Hospital
- Start
- Aug 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Cork University Hospital. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01314144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314144.